Sanofi India Faces Continued Stock Decline Amid Broader Market Weakness

Sanofi India has experienced a significant decline today, with shares dropping by 5.34% as of August 1, 2025. This performance marks a continued downward trend, as the stock has now fallen for two consecutive days, resulting in a total decline of 5.82% over this brief period. The stock reached an intraday low of Rs 5549.7, reflecting a 5% decrease at its lowest point.
In comparison to the broader market, Sanofi India underperformed its sector, which saw a decline of 3.21% in the Pharmaceuticals & Drugs industry. The stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend.

Over the past month, Sanofi India has recorded a 10.82% decline, while the Sensex has only fallen by 3.72%. Year-to-date, the stock is down 9.29%, contrasting sharply with the Sensex's gain of 3.13%. Over the longer term, Sanofi India's performance has also lagged, with a 28.82% decline over the past five years compared to the Sensex's impressive growth of 114.27%.